DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Hughes AJ, Bishop S, Kleedorfer B. et al
Subcutaneous apomorphine in Parkinson's disease:
response to chronic administration for up to 5 years.
Mov Disord 1993; 6: 165-170
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.